IL1B and psoriasis: The IL-1 pathway resulted hyperactive in HS, and van der Zee and colleagues showed not only that IL-1β levels were significantly elevated both in lesional and perilesional HS skin, but that they were also higher than in psoriasis skin (the prototype inflammatory skin disease) [114].